Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes

  • Vardenafil prevents the development of HFpEF
  • Csaba Mátyás, Balázs T. Németh, Attila Oláh, Marianna Török, Mihály Ruppert, Dalma Kellermayer, Bálint A. Barta, Gábor Szabó, Gábor Kökény, Eszter M. Horváth, Beáta Bódi, Zoltán Papp, Béla Merkely, Tamás Radovits
  • European Journal of Heart Failure, December 2016, Wiley
  • DOI: 10.1002/ejhf.711

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1002/ejhf.711

In partnership with: